Cancer Vaccine Breaking News

Cancer vaccine breaking news brought to you by Vax Before Cancer.

Dec 9, 2025 • 2:25 pm CST
Frontiers 2023

The University of Oxford announced today that it has launched the world's first Phase II clinical trial of a Nipah virus vaccine candidate in Bangladesh in partnership with the International Centre for Diarrhoeal Disease Research.

This study is essential, as a vaccine is urgently needed, as the disease can be fatal in up to 75% of cases. 

Funded by the Coalition for Epidemic Preparedness Innovations, this study will assess the safety and immune response of the ChAdOx1 NipahB vaccine in a region where the virus causes recurrent outbreaks.

The ChAdOx NipahB vaccine was manufactured for this clinical trial by the Serum Institute of India Pvt. Ltd., the world's largest vaccine manufacturer.

Professor Brian Angus, Professor of Medical Practice at the Nuffield Department of Medicine, University of Oxford and Chief Investigator of the trial at the Oxford Vaccine Group, commented in a press release on December 9, 2025, "Starting a Phase II trial in a country affected by regular Nipah outbreaks is a critical step in making sure this vaccine is both effective and relevant to the people who need it most."

"It's an essential part of ensuring equitable access to protection against emerging infectious diseases." 

Nipah virus is a deadly disease from the same viral family as measles, the paramyxoviruses.

The World Health Organization recognises it as a research priority due to its pandemic potential. Of the 750 cases recorded since 1998, there have been 415 deaths related to this virus.

First identified after an outbreak in Malaysia, the Nipah virus causes small outbreaks in Bangladesh almost every year. In India, seven outbreaks of the Nipah virus have occurred since 2001, primarily occurring in the southern and eastern regions, according to a study published by the journal Frontiers.

Dec 9, 2025 • 10:39 am CST
Maps 2025

The UK Health Security Agency (UKHSA) has identified an increase in the number of Shigella sonnei cases caused by a particular strain of the gastrointestinal pathogen.

Since October 2025, there has been a rise in Shigella infections in people returning to the UK from the Republic of Cape Verde. Of the 137 confirmed UK cases, most (109) reported recent travel to Cape Verde, an island country in the Atlantic Ocean off the coast of West Africa.

As of December 5, 2025, the UKHSA had initiated an outbreak investigation.

An outbreak of Shigella sonnei was also reported in Cape Verde in 2022, with cases among travellers from several European countries, including the UK.

The UKHSA says Shigella sonnei (S. sonnei) is a species of Shigella, a group of gastrointestinal bacteria that can cause severe diarrhoea, fever, and stomach cramps; rarely, it can cause sepsis in the immunocompromised.

S. sonnei is transmitted via contact with contaminated faeces either directly through person-to-person transmission or indirectly from contaminated food or water, or surfaces – infection is often linked to overseas travel to regions where shigellosis is endemic.

In 2023, there were 117 cases in England belonging to the 10 single-nucleotide polymorphism linkage cluster t10.1814.

Globally, most cases of shigellosis are in children younger than five years of age, but all ages can be affected. There is also a risk of sexual transmission among certain people.

In the United States, as of Week 43, the CDC reported about 14,000 Shigellosis cases, a significant decrease from 2024.

As of December 9, 2025, the CDC states there is no vaccine to prevent Shigella infection.

Dec 9, 2025 • 9:38 am CST
Walgreens December 2025

Over the past week, reports of influenza cases have been confirmed across the United States, with a few states reporting outbreaks.

According to the Walgreens Respiratory Illness Index on December 9, 2025, Louisiana, Puerto Rico, Hawaii, and Georgia are the most recent, unfortunate leaders reporting flu outbreaks.

Previously, the latest FluView published by the Centers for Disease Control and Prevention (CDC) reported that 2.9% of visits to healthcare providers in the prior week were for respiratory illnesses, up from 2.5%.

The best data from the CDC is that no influenza-associated pediatric deaths occurred during the 2025-2026 season. Last flu season, 287 pediatric deaths were reported.

With the peak influenza season fast approaching, the CDC encourages most people to get their annual vaccination as soon as possible.

Dec 8, 2025 • 3:41 pm CST
Maps 2025

The South Carolina Department of Public Health (DPH) recently announced that seven of the new measles cases being investigated are centered in Spartanburg County.

As of December 5, 2025, there are currently 281 individuals in quarantine and two in isolation in the center of South Carolina. This county is located north of Columbia, SC, and west of Charlotte, NC.

DPH says that since the outbreak began in early October 2025, some cases are travel-related or due to close contact with known cases. Other cases have no identified source, suggesting that measles is circulating in the community and could spread further. 

DPH will continue to prioritize requests for MMR vaccination events, if received, and will also take steps to increase appointment availability for MMR vaccination in health department locations, should demand dictate.

MMR vaccines are also available at many primary care provider offices and pharmacies, as well as DPH Health Departments. 

Additionally, the U.S. CDC maintains a Global Travel Health Notice regarding measles outbreaks in numerious countries. The CDC recommends that before traveling abroad in December 2025, you ensure you and your family are fully immunized against the contagious virus. 

Dec 8, 2025 • 1:17 pm CST
Jamaica Heath Ministry December 2025

After Hurricane Melissa struck in late October 2025, Jamaica's Ministry of Health declared a health emergency across the island regarding leptospirosis (Weil's disease).

The passage of Hurricane Melissa led to flooding in many communities, increasing the risk of leptospirosis transmission. By early December 2025, the ministry reported (#36) 71 suspected, probable, or confirmed leptospirosis cases following the hurricane.

Among these cases, seven fatalities have been confirmed as related to leptospirosis.

Local media reported on December 5, 2025, that the ministry is monitoring the ongoing outbreak in St James (15 cases), St Ann (12), and St Elizabeth (8).

Dr. Ciro Ugarte, PAHO Health Emergencies director, recently stated in a press release, "Our priority is to ensure that communities have access to safe, quality health care while remaining vigilant to rapidly detect and respond to health threats that linger in the aftermath of the hurricane."

Additionally, Jamaica's National Surveillance Unit, Ministry of Health and Wellness, had recorded 452 suspected/probable cases of dengue and two suspected dengue-related deaths in 2025.

While the U.S. CDC has not issued a Travel Health Notice as of December 8, 2025, the UK's the Foreign, Commonwealth & Development Office says there is no vaccination or medication to prevent leptospirosis.

And when departing from the U.S., the second-generation dengue vaccine is currently unavailable.

Dec 8, 2025 • 10:05 am CST
Google Maps December 8, 2025

Hong Kong's chikungunya fever (CF) outbreak continues to include both travel-related and locally acquired cases in 2025.

Today, the Hong Kong Centre for Health Protection (CHP) of the Department of Health reported that there have now been 10 local CF cases and 68 cases among travelers.

The CHP wrote on December 7, 2025, that some confirmed CF cases had reportedly been bitten by mosquitoes while hiking along the Tsing Yi Nature Trails, a higher-risk area.

The CHP continued to urge individuals who have recently visited the Tsing Yi North area or hiked along the Tsing Yi Nature Trails to seek medical attention as soon as possible if they develop relevant symptoms and to call the enquiry hotline (Tel: 2125 2373).

The CHP continued to urge the members of the public residing and working at Queen's Road West (near Morrison Street and Hollywood Road) who experienced a fever, rash, or joint pain on or after November 15, 2025, to seek medical advice or contact the CHP immediately.

This area is located northwestern of the inner city and east of Hong Kong Disneyland.

CHP officers continued to reach out to individuals in the locations above, reminding them to be aware of relevant symptoms and to maintain good household hygiene.

To alert international travelers to at-risk areas, the U.S. CDC issued Travel Health Notices in 2025.

As of December 5, 2025, the CDC added Bangladesh and Sri Lanka to the Level 2 notice list.

In the Region of the Americas, over 289,000 CF cases and 141 related fatalities have been reported this year. The majority of these cases have been confirmed in Bolivia, Brazil, and Cuba.

The CDC writes 'You can protect yourself by preventing mosquito bites, which includes using insect repellent. Vaccination is recommended for travelers visiting any area with a CF outbreak in 2025.'

In the United States, chikungunya vaccination services are offered at travel clinics and pharmacies.

Dec 8, 2025 • 8:34 am CST
India December 2025

Throughout 2025, India has reported an increase in dengue cases across most regions. With the new year fast approaching, the National Centre for Vector Borne Disease Control (NCVBDC) data indicates a difficult season for this mosquito-transmitted disease in 2026.

The NCVBDC data indicate that, in October 2025, a total of 22,659 dengue cases were reported in India, a 21% increase compared to September 2025 (18,803). Tamil Nadu is the unfortunate leader in 2025.

And as of December 2025, over 49,000 dengue cases had been reported.

When the U.S. CDC last updated its Level 1 - Practice Usual Precautions, the Global Travel Health Notice focused on dengue outbreaks; it did not include a warning for India. However, the CDC says Travelers visiting dengue outbreak countries may be at increased risk in 2025.

Furthermore, the CDC has identified a higher-than-expected number of dengue cases among U.S. travelers returning from those countries, including those arriving in Florida.

While the CDC does not recommend the second-generation dengue vaccine known as Qdenga, various countries do offer it in December 2025.

Dec 8, 2025 • 7:22 am CST
WHO December 8, 2025

The World Health Organization (WHO) has published its 60th situation report on the multi-country mpox outbreak. Since May 2022, when the mpox outbreak was first recorded, the WHO's report offers insights into the global epidemiological situation and includes updated data on this severe disease.

As of December 8, 2025, the WHO stated that all clades of the monkeypox virus (MPXV) continue to circulate. When mpox outbreaks are not rapidly contained, and human-to-human transmission is not interrupted, there is a risk of sustained community transmission.

For example, in October 2025, 44 countries across all WHO regions reported 2,501 new confirmed mpox cases, including 12 related deaths, for a case fatality ratio of 0.5%. About 75% of these cases were reported in the African Region. 

Outside Africa, local transmission of clade Ib MPXV has been occurring in Italy, the Netherlands, Portugal and Spain, the United States of America, and Malaysia.

New imported mpox cases due to clade Ib MPXV have been detected among travellers in Belgium, Germany, Greece, and the United Kingdom of Great Britain and Northern Ireland.

According to the U.S. CDC, mpox is a vaccine-preventable disease and is recommended for those at risk.

Getting both recommended JYNNEOS doses provides the best protection against monkeypox.

The CDC says that whether or not you've been vaccinated, you can continue to reduce your risk of getting monkeypox.

 

Dec 5, 2025 • 10:12 am CST
Post on X

In an effort to reduce the ongoing Marburg Virus Disease (MVD) outbreak in Ethiopia, the Sabin Vaccine Institute has announced that it has sent about 640 doses of its investigational cAd3-Marburg Vaccine to Ethiopia.

As of December 5, 2025, there are currently no licensed vaccines or treatments for MVD.

Sabin's single-dose cAd3-Marburg Vaccine is being used in a Phase 2 outbreak clinical trial in Rwanda; the vaccine is also in Phase 2 clinical trials in the U.S., Uganda, and Kenya. 

"The Ethiopian Ministry of Health reached out to Sabin early in the outbreak, and we have been working in partnership to support Minister of Health Dr. Mekdes Daba and her team," says Sabin Chief Executive Officer Amy Finan, in a press release.

"We've built on our previous outbreak response experience to assist our Ethiopian colleagues as requested quickly."

The Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services' Administration for Strategic Preparedness and Response, funds the development and manufacture of Sabin's investigational vaccine candidate.

Ethiopia's Ministry of Health recently confirmed 13 Marburg infections, including eight deaths, in its latest update. 

Dec 5, 2025 • 9:49 am CST
US CDC

The Ministry of Health, Families, Autonomy and Persons with Disabilities, and Public Health France have been informed of two cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in France.

According to a press release dated December 4, 2025, these two cases were confirmed based on suggestive symptoms and a history of shared travel to the Arabian Peninsula. Management measures have been implemented to limit the risk of virus transmission.

These two cases occurred in individuals who had participated in the same trip, but no secondary transmission chains have been identified within the country at this stage. The other individuals who participated in the trip have also been monitored since the identification of the first confirmed case.

In France, only two cases were recorded as of 2013.

MERS-CoV is a virus that was first identified in Saudi Arabia in 2012 and is primarily transmitted from animals to humans. Since then, more than 2,600 cases of MERS-CoV have been reported worldwide.

The virus is endemic to dromedary camels and bats in the Arabian Peninsula and parts of Africa. 

France says: if you experience these symptoms and have recently traveled to these areas and/or been in contact with people who have experienced them, do not hesitate to consult your doctor.

Dec 4, 2025 • 8:00 am CST
CDC, Pandemic Sciences Institute, University of Oxford, 2025

The first volunteer has received a dose in Oxford Vaccine Group's first-in-human trial of the Lassa vaccine, marking a significant milestone in the fight against the deadly virus, which was first discovered in the late 1960s.

The trial, funded by the Coalition for Epidemic Preparedness Innovations, will assess the safety and immune response of the ChAdOx1 Lassa vaccine.

Commenting on the launch of the trial, Professor Maheshi Ramasamy, Chief Investigator of the trial at the Oxford Vaccine Group, commented in a press release on December 4, 2025, "Vaccines are one of the most powerful tools we have in global health: they save lives, stop outbreaks, and strengthen health systems, and so we're delighted to start the VITAL01 Lassa fever vaccine study here in Oxford."

The World Health Organization has identified Lassa fever and related viruses as priority pathogens in urgent need of research and development because they pose a significant public health risk due to their potential to cause large outbreaks. Experts estimate that up to 700 million people could live in regions at risk of Lassa fever by 2070, although there are currently no licensed vaccines or treatments for Lassa fever.

In addition to the launch of new clinical trials, plans to advance a Lassa vaccine to licensure are progressing through regional leadership and coordination by the Lassa fever Coalition.

 

 

 

Dec 3, 2025 • 11:48 am CST
Google Maps December 2025

The Centre for Health Protection (CHP) of the Department of Health announced today that the CHP has recorded a total of 76 confirmed Chikungunya fever (CF) cases this year.

As of December 2, 2025, seven CF cases were local, and the rest were imported. Furthermore, the risk of imported cases persists.

Recently, the CHP also informed approximately 130 primary care doctors in Kwai Tsing District, located north west of Hong Kong, urging them to closely monitor patients with compatible symptoms and arrange blood tests for those concerned. The CHP's Public Health Laboratory Services Branch will provide free virus testing services.

The CHP's media statement confirmed all relevant departments have comprehensively enhanced the mosquito control operations in Hong Kong since July 2025, and this has continued.

Controlling this mosquito-transmitted disease is essential as the symptoms are generally self-limiting and last for a few days, while in some cases, joint pain may persist for several months or even years. Severe symptoms and deaths from Chikungunya are rare and usually related to other coexisting health problems.

Although the northern hemisphere has entered the winter, temperatures in subtropical and some temperate regions remain elevated due to climate change, creating favourable conditions for mosquito breeding and the transmission of viruses, such as Chikungunya.

In addition, CF outbreaks continue to occur in many countries worldwide.

Since the beginning of 2025, and as of September 30, a total of 445,271 suspected and confirmed CF cases and 155 CF-related deaths have been reported in 40 countries/territories. Cases have been reported in the Americas, Africa, Asia, and Europe.

To alert international travelers departing from the United States, the US CDC has published Level 2 - Practice Enhanced Precautions, Travel Health Advisories for countries in the Indian Ocean and Cuba.

In Florida, over 60 Chikungunya cases have been associated with visitors from Cuba.

The CDC advises travelers to consult a travel vaccine expert about Chikungunya immunization options before visiting these countries in 2025.

Dec 3, 2025 • 8:16 am CST
US CDC 2025

The US CDC's Weekly US Influenza Surveillance Report for Week #47 for 2025 recently offered these insights regarding respiratory disease activity, including Influenza.

The CDC states that 'seasonal influenza activity remains low nationally but is increasing in a few states, such as Colorado and Louisiana, primarily among children and young adults.'

Additionally, the percent positivity for Influenza and the percentage of outpatient visits for respiratory illness and emergency department visits for Influenza among pediatric age groups increased this week.

And the timing of these increasing activities is similar to that of several past flu seasons, with peaks expected during early 2026.

The best news posted by the CDC on December 1, 2025, is that no influenza-associated pediatric deaths occurring during the 2025-2026 season have been reported to the CDC.

From a disease prevention option, the CDC says vaccine manufacturers have projected that they will supply the United States with as many as 154 million doses of flu vaccine for 2025-2026. Most of the projected influenza vaccine supply produced this influenza season does not contain thimerosal as a preservative.

These flu shots are generally available at community pharmacies.

Dec 2, 2025 • 12:52 pm CST
Google Maps 2025

Speaking at a recent press conference, Jamaica's Minister of Health & Wellness, Dr. the Hon. Christopher Tufton, CD MP, noted that while the Caribbean island country has managed the recent Leptospirosis outbreak following the passage of Hurricane Melissa, there is no great risk to tourists coming to Jamaica.'

According to the Minister on November 28, 2025, "We have discerned no great risk as it relates to facilities that cater to tourists, including hotels and attractions. There is a certification process that is required for these facilities, and this is done collaboratively with the local health and tourism authorities."

"We are not giving an advisory to discourage visitors, but to alert the vulnerable communities, which have been identified."

Jamacia reported that between October 30 and November 20, 2025, a total of 9 confirmed and 28 suspected cases of leptospirosis were reported in eight parishes, including St. Ann, St. Mary, St. James, Hanover, Westmoreland, St. Elizabeth, St. Catherine, and Trelawny.

According to the U.S. CDC, Leptospirosis is a disease caused by the bacterium Leptospira and can be transmitted through contaminated water or soil. Without treatment, leptospirosis in people can lead to kidney damage, meningitis, liver failure, trouble breathing, and even death.

Leptospirosis is found worldwide, including throughout the United States. About 1 million cases occur globally each year, with nearly 60,000 deaths.

As of December 2, 2025, the CDC has not issued a Travel Health Notice regarding this outbreak in Jamaica, and reports that no preventive vaccines are currently available for this disease.

Dec 2, 2025 • 10:32 am CST
US CDC December 2025

The Republic of Haiti has the highest rate of human rabies in the Western Hemisphere, with infected dogs being the primary carriers of this severe virus.

According to the U.S. Centers for Disease Control and Prevention (CDC), Level 1 - Practice Usual Precautions, Travel Health Notice issued on November 25, 2025, there have been an increased cases of rabies reported in animals and humans in Haiti.

Additionally, one case of rabies has been reported in the U.S. in a traveler from Haiti.

The CDC writes that travelers to Haiti, located on the western portion of the Caribbean island of Hispaniola, who may have been exposed to rabies, should immediately seek medical care. Upon returning home, travelers should follow up with their health care provider as soon as possible.

The CDC previously confirmed that rabies is a vaccine-preventable disease for both animals and people.

Achieving an estimated 80% vaccination coverage among Haiti's dog population, as recommended by PAHO's Regional Rabies Elimination Program and the Directors of Rabies Programs in the Americas, is expected to reduce rabies virus circulation in dogs significantly.

"Despite the challenges and limitations posed by the security situation and the overall instability in the country, we consider this vaccination campaign a significant success," said Dr Haïm Joseph Corvil, Protection Unit Coordinator at the Ministry of Agriculture, Natural Resources and Rural Development, in a previous PAHO media release.

And the CDC says: Consider getting vaccinated against rabies before travel if you might come into contact with dogs, cats, or wildlife, or plan to work with animals during a visit to Haiti.

In the United States, travel clinics and pharmacies currently offer preventive and reactive rabies vaccination services.